• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

Upp till 20% på populära nyheter →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare

    Mina sidor

      Hjälp

      • Kundservice
      • Vanliga frågor och svar
      • Frakt och leverans
      • Retur vid ångerrätt
      • Reklamera vara
      • Betalning
      • Köpvillkor
      • Allmänna villkor
      • Information om webbplatsens tillgänglighet

      Om Bokus

      • Om oss
      • Pressrum
      • För studenter
      • För företag
      • För bibliotek och offentlig verksamhet
      • För leverantörer
      • Hållbarhet

      Populärt

      • Aktuella erbjudanden
      • Presentkort
      • Studentlitteratur
      • Nya böcker
      • Topplistor
      • Signerade böcker
      • Engelska böcker

      Inspiration

      • Boktips
      • BookTok
      • Populära bokserier
      • Barnbokskaraktärer
      • Populära författare
      Logotyp för Bokus
      Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
      bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
      Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
      1. Medicin
      2. Klinisk medicin och internmedicin
      3. Sjukdomar och rubbningar
      4. Onkologi

      Acute Leukemias

      AvStefan H. Faderl,Hagop M. Kantarjian

      Inbunden, Engelska, 2020

      Del i serien Hematologic Malignancies

      1 687 kr

      Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

      Beskrivning

      The new edition of this well-received book provides a timely update of current knowledge on the biology, disease classification, and treatment of the acute leukemias – acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Throughout, the focus is on the provision of state of the art information and guidance that will meet the needs of clinicians. Chapters have been extensively revised to take into account advances in understanding and management that have been achieved over the past few years. In addition, new chapters have been included on selection of AML patients for therapy, a broader discussion of stem cell transplantation in AML, the role of immunotherapy in ALL, the approach to newly diagnosed pediatric ALL, and the diagnosis and management of BCR-ABL-like ALL. New therapies, including investigational ones, are fully covered. As progress continues in the management of acute leukemias this book will be a valuable asset for clinicians at all levels of experience.

      Produktinformation

      • Utgivningsdatum:2020-10-11
      • Mått:178 x 254 x 21 mm
      • Vikt:825 g
      • Format:Inbunden
      • Språk:Engelska
      • Serie:Hematologic Malignancies
      • Antal sidor:289
      • Upplaga:2
      • Förlag:Springer Nature Switzerland AG
      • ISBN:9783030536329

      Utforska kategorier

      • Onkologi inom Medicin
      • Hematologi inom Medicin

      Mer om författaren

      Stefan H. Faderl, MD, graduated in 1990 from Ludwig-Maximilians University in Munich, Germany. After fellowship training in Medical Oncology at the MD Anderson Cancer Center,  Dr. Faderl joined the Leukemia Department at MD Anderson Cancer Center, where he worked on acute and chronic leukemias and rose to the rank of full professor. During this time he was engaged in the development of several new agents for the treatment of leukemia. In 2013, Dr. Faderl took the position as Chief of Leukemia at the John Theurer Cancer Center at Hackensack University Medical Center, where he successfully grew the clinical and clinical research programs. In 2017 he transitioned to the pharmaceutical industry where he continues developmental work towards new therapies for oncology patients. Dr. Faderl is the author of numerous journal articles, book chapters, abstracts, and editorials.Hagop M. Kantarjian, MD, is a professor and chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, TX. Also, he is the Samsung Distinguished Leukemia Chair in Cancer Medicine and a Special Fellow on Healthcare Policies at the Rice University Baker Institute in Houston, TX and and advocates for healthcare issues pertinent to patients with cancer and leukemia.Dr Kantarjian’s research focuses on translational-clinical developmental therapeutics in leukemia. In the past 3 decades, he has made several contributions that improved the prognosis and survival in patients with chronic myeloid leukemia (tyrosine kinase inhibitors, eg, imatinib, dasatinib, nilotinib, bosutinib, ponatinib which improved the 10-year survival from 20% to 90%), in acute lymphocytic leukemia (H-CVAD regimen and its derivatives; antibodies including blinatumomab and inotuzumab), the discovery of decitabine for the treatment of myelodysplastic syndrome, and of clofarabine for the treatment of leukemias, among others. His research and collaborations were the basis for the FDA approvals of several drugs in leukemia.Elihu Estey, MD, has been involved in clinical research in acute myeloid leukemia (AML) for almost 40 years, the first 30 at MD Anderson Cancer Center in Houston, and the past 9 at the University of Washington Medical Center and the Fred Hutchinson Cancer Research Center, Seattle (UW/FHRCH). While at MD Anderson he was the first to report use of all-trans retinoic acid and arsenic trioxide without cytotoxic chemotherapy for treatment of newly diagnosed acute promyelocytic leukemia, which is now the standard worldwide. He also implemented a selection design for comparing new therapies in AML, which formed the basis for the “play-the-winner” designs used in trials in older patients. At UW/FHCRC he suggested the feasibility of early discharge from hospital after intensive induction therapy for AML. Dr. Estey coordinates UW/FHCRC non-transplant AML clinical research and has made major contributions tothe development of the European LeukemiaNet AML guidelines and before that the International Working Group AML Guidelines.  He regularly publishes in Blood, JCO, and Leukemia and in 2016 wrote an NEJM editorial on therapeutic implications of AML molecular subtypes.

      Innehållsförteckning

      • Part I Acute Myeloid Leukemia.- Acute Myeloid Leukemia: Epidemiology and Etiology.- Clinical Presentation, Diagnosis and Classification of Acute Myedloid Leukemia.- Selection of Patients for Therapy.- Therapy of Newly Diagnosed AML.- Management of Relapsed and Refractory AML.- Stem cell Transplant in AML.- Investigational Therapies in AML.- Acute Lymphoblastic Leukemia.- Acute Lymphoblastic Leukemia: Epidemiology abnd Etiology.- Molecular Biology and Genetics.- Acute Lymphoblastic Leukemia: Clinical Presentation, Diagnosis, and Classification.- Therapy of Newly Diagnosed Adult ALL.- Approach to Newly Diagnosed Pediatric and AYA ALL.- The Role of Immunotherapy in ALL.- STem Cell Transplantation in the Treatment of ALL.- The Significance of Minimal Residual Disease in Acute Lymphoblastic Leukemia.- Philadelphia Chromosome - Positive Acute Lymphoblastic Leukemia.- BCR-ABL-like ALL: Diagnosis and Management.- Burkitt's Acute Lymphoblastic Leukema in Adults.- Treatment of Lymphoblastic Lymphoma in Adults.- Central Nervous System Involovment in Adult Acute Lymphocytic Leukemia.- Management of Relapsed and Refractory ALL.- Emergencies in Acute Lymphoblastic Leukema.- Investigational Therapies in ALL
      Hoppa över listan

      Du kanske också är intresserad av

      Stefan H. Faderl, Hagop M. Kantarjian, Elihu Estey - Acute Leukemias, Häftad

      Acute Leukemias

      Stefan H. Faderl, Hagop M. Kantarjian, Elihu Estey

      Häftad, 2021

      1 239 kr

      Elihu Estey, Hagop M. Kantarjian, Stefan H. Faderl - Acute Leukemias, E-bok

      Acute Leukemias

      Elihu Estey, Hagop M. Kantarjian, Stefan H. Faderl

      E-bok
      2020

      1 516 kr

      Susan O'Brien, Julie M. Vose, Hagop M. Kantarjian - Management of Hematologic Malignancies, Inbunden

      Management of Hematologic Malignancies

      Susan O'Brien, Julie M. Vose, Hagop M. Kantarjian

      Inbunden, 2010

      2 529 kr

      Hagop M. Kantarjian - MD Anderson Manual of Medical Oncology, Fourth Edition, E-bok

      MD Anderson Manual of Medical Oncology, Fourth Edition

      Hagop M. Kantarjian

      E-bok
      2022

      3 024 kr

      Martin Dreyling, Marco Ladetto - Indolent Lymphomas, Inbunden

      Indolent Lymphomas

      Martin Dreyling, Marco Ladetto

      Inbunden, 2021

      1 687 kr

      Michael Hallek, Barbara Eichhorst, Daniel Catovsky - Chronic Lymphocytic Leukemia, Inbunden

      Chronic Lymphocytic Leukemia

      Michael Hallek, Barbara Eichhorst, Daniel Catovsky

      Inbunden, 2019

      1 015 kr

      Morie A. Gertz, Philip R. Greipp - Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders, Häftad

      Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders

      Morie A. Gertz, Philip R. Greipp

      Häftad, 2010

      2 242 kr

      Rüdiger Hehlmann - Chronic Myeloid Leukemia, Häftad

      Chronic Myeloid Leukemia

      Rüdiger Hehlmann

      Häftad, 2018

      1 463 kr

      Oliver A. Cornely, Martin Hoenigl - Infection Management in Hematology, Häftad

      Infection Management in Hematology

      Oliver A. Cornely, Martin Hoenigl

      Häftad, 2021

      1 127 kr

      Georg Lenz, Gilles Salles - Aggressive Lymphomas, Inbunden

      Aggressive Lymphomas

      Georg Lenz, Gilles Salles

      Inbunden, 2019

      1 463 kr